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Abstract
Background: Comprehensive information about national spending on prevention is crucial for
health policy development and evaluation. This study provides a comprehensive overview of
prevention spending in the Netherlands, including those activities beyond the national health
accounts.
Methods: National spending on health-related primary and secondary preventive activities was
examined by funding source with the use of national statistics, government reports, sector reports,
and data from individual health associations and corporations, public services, occupational health
services, and personal prevention. Costs were broken down by diseases, age groups and gender
using population-attributable risks and other key variables.
Results:  Total expenditures on prevention were €12.5 billion or €769 per capita in the
Netherlands in 2003, of which 20% was included in the national health accounts. 82% was spent on
health protection, 16% on disease prevention, and 2% on health promotion activities. Most of the
spending was aimed at the prevention of infectious diseases (34%) and acute physical injuries (29%).
Per capita spending on prevention increased steeply by age.
Conclusion:  Total expenditure on health-related prevention is much higher than normally
reported due to the inclusion of health protection activities beyond the national health accounts.
The allocative efficiency of prevention spending, particularly the high costs of health protection and
the low costs of health promotion activities, should be addressed with information on their relative
cost effectiveness.
Background
In the 20th century, preventive activities resulted in major
improvements in public health [1]. Among the most sig-
nificant activities are sewerage systems, road safety, vacci-
nations and clean water technologies. Particularly the
latter have contributed considerably to the decrease in
mortality in the late 19th and early 20th century [2].
In contrast to their public health impact, the share of pre-
vention in total health expenditures is often claimed to be
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small [3]. In the USA, expenditures on prevention
included in the national health accounts (NHA) were esti-
mated at 3% of total national health expenditure in 1988
[4]. This share was recently estimated for 22 OECD coun-
tries, ranging from 0.6% (Italy) to 8% (Canada) [5]. How-
ever, expenditures that include only prevention within the
NHA are an underestimate as major public health inter-
ventions (such as clean water and air, sanitation, and road
traffic safety) are managed by different departments out-
side the health care sector. This was illustrated by the CDC
report mentioned above, in which the total amount spent
on prevention was almost double the prevention expendi-
tures within the NHA [4].
New preventive and curative health technologies are
being developed continuously, and health authorities are
faced with decisions about allocating resources towards
these technologies, in addition to (or as substitute for)
existing interventions. This requires knowledge on the
effectiveness, resource use, and costs of new and existing
technologies. Differences in cost effectiveness indicate
that we could save lives more effectively and efficiently
[6]. Regarding prevention, the search for efficiency (costs
per unit of health gained) is complicated because it
extends to other policy budgets, and the health claims of
prevention have to compete with other policy objectives.
Accordingly, comprehensive information about national
spending on prevention is crucial for health policy devel-
opment and evaluation. We present here an overview of
the costs of health-related preventive activities in the
Netherlands in 2003, both inside and outside the health
care sector, as a framework for more detailed (cost-effec-
tiveness) analyses. Costs are broken down by different cat-
egories, disease groups, age and gender, and will also be
discussed from the perspective of expenditure on curative
services and long-term care.
Methods
Identification of preventive activities
We considered preventive activities conducted by (semi-
)government, trade and industry, and consumers (societal
perspective). We identified these preventive activities as
follows. First, we consulted overview articles or (policy)
reports [7-12], that had the explicit aim of giving an inte-
gral description of preventive health activities. Supple-
mentary, we consulted experts to fill up the overview of
different preventive activities in the Netherlands as good
as possible. These experts were policy makers of different
Ministries, scientific researchers (e.g. in the field of public
health, environment, or medicine), and employees of dif-
ferent institutes (e.g. fire department, police, or center for
alcohol and drugs dependence). Finally, we searched on
the Internet for more detail on the preventive activities
suggested by these experts. We used the database Medline
and the search machine Google to identify published
studies or (policy) reports about these activities.
We included primary and secondary preventive activities
(except for preventive medication, such as cholesterol
suppressants and anti-hypertensives, for which we
included primary prevention only). Tertiary preventive
activities were excluded because these are difficult to sep-
arate from usual patient care.
Preventive activities performed by actors integrated in the
NHA (e.g. dental practices, mental health care, GP prac-
tices, and Occupational Health Services) were all seen as
relevant and included. Preventive activities considered
outside the NHA (e.g. rule enforcement of drugs, alcohol,
and smoking, activities to guarantee traffic safety, and
reduction of noise pollution) all aim to protect or pro-
mote health. However, some interventions are not exclu-
sively aimed at promoting health, but also serve other
sources of welfare, such as a clean (e.g. domestic waste dis-
posal), comfortable (e.g. noise barriers), and safe (e.g.
prevention of violence) environment, either physical or
social. We included those interventions for which the pro-
motion of health is the principal policy objective or has
been the dominant motive by the time of introduction,
even though these interventions were not exclusively
aimed at promoting health. For this, we relied to a great
extent on expert opinions. Although the existence of mul-
tiple policy objectives is evident for specific interventions,
valid criteria are lacking to break down the expenditures
of these interventions by separate policy objectives.
Preventive activities aimed at sports were partly included
(e.g. promoting sport as a public initiative) due to a dom-
inant public health aim, whereas this was not the case for
sports in general (e.g. health clubs, club membership,
time investment at sports, and expenditures on sport
material). Education was not labeled as prevention,
although schools can play an important role in promoting
healthy lifestyles regarding nutrition and sexual behavior.
Although excise duties (such as tobacco and alcohol
taxes) are important public health instruments, they were
not included since from a societal perspective they must
be regarded as transfer payments rather than real (oppor-
tunity) costs.
Data collection
Various sources were used to quantify the expenditures on
selected preventive measures: national statistics [10], gov-
ernment reports [13-15], sector reports [8,16], and data
from individual health associations and corporations [17-
27], public agencies [28,29], occupational health services
[30,31], and personal prevention. An overview of preven-
tive activities, data sources, and types of cost calculationBMC Public Health 2007, 7:252 http://www.biomedcentral.com/1471-2458/7/252
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method is given in Additional file 1. All expenditures
relate to operational expenditures and include personnel,
material, equipment, housing, maintenance and over-
head costs. All data are from the year 2003. First, we col-
lected existing financial data of preventive activities on the
national level to avoid double counting. We used annual
reports (e.g. Benchmark report Municipal Health Services
[29], Netherlands Environmental Health Agency [8],
Dutch anti-smoking group STIVORO [26], Netherlands
Nutrition Center[24]) and also consulted experts (Dutch
Society for Oral Health Education, Ministry of Education,
Culture and Science, Food and Consumer Product Safety
Authority). Second, if no data were available at national
level, we collected financial data on preventive activities at
regional level. We used annual reports and (official) bal-
ance sheets of different providers or collected financial
data by consulting experts (e.g. Centers for Alcohol and
Drugs dependence, fire departments). If annual reports or
financial data were not available for all providers perform-
ing a certain preventive activity (e.g. not all Centers for
Alcohol and Drugs dependence responded), we extrapo-
lated the expenditures by using the related population fig-
ures. Finally, expenditures on personal preventive
activities were collected with the help of retail data. We
asked providers, or used statistics, concerning how much
of a specific product (e.g. cholesterol suppressants, con-
doms, vitamins) was sold.
Data analysis
On aggregate level we analyzed the distribution of preven-
tive expenditure from a societal perspective as well as from
a more restricted health care perspective as used in NHA
and in the System of Health Accounts (SHA) developed by
the OECD. Then, all identified preventive measures were
classified as either health promotion, health protection,
or disease prevention. Health promotion is aimed at pro-
moting healthy behavior through information and educa-
tion; health protection is aimed at reducing exposure to
environmental health risks by legislation, control, and
interventions; disease prevention includes preventive
medication, vaccination, and screening. Health promo-
tion and health protection are both aimed at a specific
determinant and not directly at a specific disease. Disease
prevention is disease specific, and includes primary pre-
ventive activities (i.e. aimed at a determinant of a specific
disease) as well as secondary preventive activities (i.e.
aimed at a specific disease). Although most preventive
activities could be uniquely classified (e.g. information
about healthy food, smoking cessation campaigns, and
swimming education could be classified entirely to health
promotion; rule enforcements of employment condi-
tions, drugs, alcohol and smoking could be classified to
health protection; National Vaccine Program, cervical
cancer screening program, and blood pressure suppres-
sants could all be classified to disease prevention), some
preventive measures overlapped multiple categories. For
instance, expenditure on youth health care by municipal
health services was divided into disease prevention
(screening activities, 85%) and health promotion (15%)
based on contact guidelines and expert consultation. Pre-
ventive activities of occupational health services were
entirely allocated to health protection, although a minor-
ity of activities can be regarded as disease prevention (e.g.
health check-ups) or health promotion (e.g. education
about work posture and physical load); this was guided by
expert opinion since registration data were unavailable.
Similarly, preventive activities by fire departments were
classified as health protection because they are predomi-
nantly directed as risk assessment and enforcement of fire
safety regulations, whereas no specific information was
available on information and education activities under-
taken by fire brigades.
Preventive expenditures were allocated to age groups (0–
19, 20–44, 45–64, 65+ years), gender, and disease groups
using key variables. For example, we used figures on
screening participation to allocate expenditures on the
national breast cancer screening program to women in the
different age groups. Similarly, expenditures of choles-
terol-lowering therapy were allocated to age and gender
by drugs-dispensing data from the 2003 national registry
on pharmaceutical care [32]. Prenatal screening expendi-
tures have been allocated to pregnant women instead of
the (unborn) child. Expenditures on health protection
were allocated to age and gender by using population fig-
ures and, more specifically, by the numbers of employees
in the case of health protection at the work place.
Disease groups were in line with the cost-of-illness
approach defined according to the 17 chapters of the ICD-
9 (International statistical Classification of Diseases, inju-
ries and causes of death)[33].
Most preventive measures could uniquely be related to
disease groups (e.g. all vaccinations, screening for TBC,
and sexually-transmitted diseases could be classified to
'infectious diseases'; preventive measures related to traffic
safety, sport injuries and fire safety could be classified to
'injuries'). Preventive measures aimed at addiction and
gambling dependence were consistently allocated to men-
tal disorders.
Some other preventive measures, however, relate to risk
factors for multiple diseases, such as smoking and obesity.
The costs of these preventive measures were allocated to
each disease group using the population attributable risk
(PAR) for mortality, which is the proportion of cause-spe-
cific deaths that is attributable to a risk factor (Additional
file 2 presents an example of allocating costs of anti-smok-
ing medication to different disease groups). According toBMC Public Health 2007, 7:252 http://www.biomedcentral.com/1471-2458/7/252
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this method the prevention costs that belong to one dis-
ease group (cause of death) are equal to the prevention
costs related to a risk factor multiplied by the relative
number of cause-specific deaths within the total number
of deaths attributable to the risk factor. This analysis was
done according to age and gender. PARs were calculated
with relative risks and prevalence of risk factors from the
literature, as used for the national Public Health Forecasts
[34]. In general, the formula for the PAR is:
where P(E) is the proportion of the general population
exposed to a particular agent, and the RR is the relative risk
(or rate ratio, or odds ratio (OR)) of disease or death for
the exposed versus nonexposed. For more information,
see also the study of Steenland et al. [35] who estimated
the annual deaths associated with occupation by calcula-
tion of PARs.
Not all preventive activities could be allocated to relevant
disease groups mainly because available data lacked suffi-
cient detail, e.g. use of vitamins, general medical examina-
tions, youth health care (excluding vaccination), housing
quality inspectorate, general health promotion, and occu-
pational prevention. These were classified as "not disease
specific".
Results
In the Netherlands, total expenditures on prevention were
estimated at €12.5 billion in 2003, equal to €769 per
inhabitant capita (Table 1). Of these, €628 per capita
(82%) was spent on health protection, €126 per capita
(16%) on disease prevention, and €15 per capita (2%) on
health promotion. The amounts spent on health protec-
tion were mainly aimed at environmental safety (€120.5
per capita; e.g. reduction of soil pollution due to agricul-
tural and industrial activities (including management of
chemicals, heavy metals, and ammonia)), traffic safety
(€99.7 per capita), domestic waste disposal (€99.1 per
capita), and the quality of air (€98.9; e.g. reduction of air
pollution by industry and traffic). Among disease preven-
tion activities, the highest amounts were spent on cardio-
vascular disease control (predominantly statins and
antihypertensives), and preventive dental health. The
amounts spent on health promotion were mainly aimed
at prevention of mental disorders (including prevention
of suicide, and supporting children of parents with mental
problems) and promoting non-specific general health.
Often more than one preventive method was used to con-
trol a risk factor or disease. For instance, traffic safety is
stimulated by health protection measures (airbags, speed
limits, and so on: €99.7 per capita), and by health promo-
tion (€0.2 per capita).
Of all expenditure on prevention, 20% (€152 per capita)
was made within the health care system and accounted for
4.3% of total health expenditure. This part of preventive
expenditure was dominated by disease-prevention activi-
ties such as cholesterol-lowering therapy, antihyperten-
sive treatment, cancer screening, and vaccination (82%).
A much smaller part was spent on health protection activ-
ities (10%, environmental safety and control by Munici-
pal Health Services and activities by occupational health
services) and on health promotion (8%).
From a societal perspective expenditure on prevention
exceeds the investments on prevention undertaken by
health providers within the scope of the health care sys-
tem. Table 2 shows the difference between our societal
estimates and the amounts that were labeled as preven-
tion in the SHA. According to the definitions of the SHA,
total spending on prevention was €139 per inhabitant.
However, according to our approach total spending on
prevention was €769 per capita. Especially inclusion of
health protection measures outside the health care system
and inclusion of preventive medication caused this differ-
ence.
Most of the spending on preventive measures was aimed
at prevention of infectious diseases (34%), followed by
injury (29%), respiratory diseases (13%), cardiovascular
diseases (8%) and mental disorders (5%) (Figure 1).
Preventive expenditures spent on health protection meas-
ures were similar across all age groups, because these
measures are aimed at the general population. The
amounts spent per person on health promotion measures
are slightly higher for children and older persons than for
younger adults (Figure 2). This reflects, for example,
swimming education for schoolchildren and prevention
of home and leisure injuries in older people. Despite that
many screening activities and vaccination programs are
directed at children, spending on disease prevention is
substantially lower among children than among those
aged 45 years and over. This is because of the high expen-
ditures associated with the use of preventive medication.
Amounts spent on prevention were slightly higher for
women, mainly due to screening for breast cancer and cer-
vical cancer, pregnancy monitoring, and the use of contra-
ceptives by teenagers (females <21 years). Females,
compared with males, also used more antihypertensives,
vitamins and osteoporosis medication.
Figure 3 shows the national spending on prevention com-
pared with expenditures on curative services and long-
term care, by disease group. Only for infectious diseases
and for acute physical injuries did the national spending
on prevention exceed the health expenditure of the partic-
ular disease groups. These high preventive expenditures
PAR
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reflect investments in expensive but effective measures
such as domestic waste disposal, clean water technology,
and traffic safety. Expenditure on cure and care for mental
disorders and diseases of the musculoskeletal system was
much higher compared with prevention costs.
Discussion
In the Netherlands expenditure on prevention in 2003
amounted to €769 per inhabitant (€12.5 billion in total),
which is much higher than usually reported. This is due to
the inclusion of health protection activities beyond the
NHA (e.g. health protection interventions related to traffic
safety, drinking water system, and air quality), that are
fourfold the prevention expenditures within the NHA
(4.3% of all health care costs). Most expenditures of pre-
ventive measures were aimed at infectious diseases (34%;
e.g. domestic waste disposal, clean water technologies,
and vaccinations) and acute physical injuries (29%; e.g.
environmental safety and traffic safety). The expenditures
on disease prevention were lowest in children and adoles-
cents, and increased steeply with age. Amounts spent on
prevention were slightly higher for women. Only for
infectious diseases and injuries were expenditures on pre-
vention higher than expenditures on curative services and
care services.
Although we aimed for a complete overview of spending
on preventive measures, data were unavailable for specific
police expenditures (e.g. maintenance of environmental
and traffic regulation, prevention of violence), prevention
by general practitioners (e.g. blood pressure surveillance,
health education), and industrial spending on food safety.
Table 1: National spending on prevention by method, in the Netherlands in 2003, in € per capita
Interventions Health
promotion (€/
capita)
Health protection
(€/capita)
Disease
prevention (€/
capita)
Total (€/capita) Total (%)
Risk factor
Smoking cessation 0.99 0.10 0.23
Alcohol dependence 0.50 0.10 0.61 0.08
Drugs dependence 0.31 0.10 0.42 0.05
Gambling dependence 0.11 0.11 0.01
Healthy food promotion and overweight 0.75 0.75 0.10
Physical activity and sport 1.49 1.49 0.19
Youth health care 1.55 8.76 10.31 1.34
Preventive dental health 0.01 30.17 30.18 3.92
Sexual health, contraception <21 years 1.19 0.73 1.91 0.25
Traffic safety 0.19 99.69 99.87 12.99
Fire prevention 0.19 3.52 3.71 0.48
Prevention of sport injuries 0.41 0.41 0.05
Prevention of home and leisure injuries 0.36 0.45 0.81 0.11
Occupational health 14.99 14.99 1.95
Violence 1.28 1.28 0.17
Noise pollution 34.48 34.48 4.48
Drinking water system and swimming water 91.63 91.63 11.91
Domestic waste disposal 99.06 99.06 12.88
Sewerage system 49.22 49.22 6.40
Food safety 9.63 9.63 1.25
Air quality 98.89 98.89 12.86
Housing quality 4.56 4.56 0.59
Environmental safety 120.50 120.50 15.67
General health (non-specific) 2.19 5.78 7.97 1.04
Disease
Mental disorders 3.73 3.73 0.48
Cancer prevention 0.95 4.26 5.21 0.68
Diabetes prevention 0.05 0.05 0.01
Cardiovascular disease control (statins, 55.70 55.70 7.24
antihypertensives)
Congenital and perinatal conditions, and 7.12 7.12 0.93
pregnancy complications
Osteoporosis 4.19 4.19 0.54
Infectious diseases: vaccinations and 8.96 8.96 1.17
screening
Total (€/capita) 14.97 628.20 125.90 769.08 100.00BMC Public Health 2007, 7:252 http://www.biomedcentral.com/1471-2458/7/252
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Data for specific consumer expenditures were also lacking
due to (many) different providers supplying one specific
preventive product in combination with no access to the
financial data concerning the product. Therefore, it was
not possible to collect (reliable) financial data on preven-
tive products such as fire alarms, sunscreen, car safety
seats, prescription-free vitamins, and bicycle helmets.
Expenditures on sports products (e.g. shoes, skis) were
ignored, because in this study these products were not
labelled as preventive activities. As a result, our figures are
still an underestimate. On the other hand, we included
interventions that were not exclusively aimed at promot-
ing health, but also serve other policy objectives (e.g. pro-
motion of physical activity was also aimed at promoting
social developments, and the sewerage system was also
aimed at promoting a clean environment). The rationale
for their inclusion was that, in these instances, health
objectives are considered to dominate other policy objec-
tives, and valid criteria are lacking to break down the
expenditures of these interventions by separate policy
objectives. If interventions directed at multiple policy
objectives would be excluded, the total prevention expen-
ditures would then be €160 per capita (€2.6 billion for
the Dutch society) instead of €769 per capita (€12.5 bil-
lion for the Dutch society). Although the inclusion of
health protection measures beyond the NHA is question-
able, in our opinion the inclusion of these measures is jus-
tified based on their positive contribution to public health
[36,37].
A second limitation of our study is that we assumed that
data from financial reports and literature (i.e. not peer
reviewed) were true, because we could not control these
data. Per definition, data taken from expert opinions are
estimations, and subdivision of expenditures in terms of
personnel, material and overhead was lacking. For this
National spending on preventive  group (ICD-9 chapters), in  the Netherlands in 2003,   per capita Figure 1
National spending on preventive methods by disease group 
(ICD-9 chapters), in the Netherlands in 2003, in € per capita.
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Table 2: Estimation of national spending on prevention in case of 
the SHA approach and the present study approach, in the 
Netherlands in 2003, in € per capita
Providers SHA (€/
capita)
Study (€/
capita)
HP.1 Hospitals
Mental health and substance 
abuse hospitals
0.68 2.33
HP.2 Nursing and residential care 
facilities
0.00 0.00
HP.3 Providers of ambulatory health care
Offices of physicians 7.53 7.76
Offices of dentists 22.97 30.07
Providers of home care services 18.53 3.52
All other providers of 
ambulatory care
0.68 7.58
HP.4 Retail sale and other providers of 
medical goods
0.00 60.59
HP.5 Provision and administration of 
public health programs
Municipal Health Services 37.06 17.67
Insitutions for cervical cancer 
research
1.30 1.31
Insitutions for breast cancer 
research
2.41 2.59
HP.6 General health administration and 
insurance
0.00 0.00
HP.7 Other industries (rest of the 
economy)
Occupational health care 
services
46.69 13.40
All other industries as secondary 
producers of health care
1.24 0.00
HP.9 Rest of the world 0.00 0.00
HP.10 Providers beyond SHA
Health promotion organisation/
association
4.76
Authorities (e.g. Ministries, 
police, municipalities)
265.62
Traffic and transport sector 47.04
Building sector 0.18
Energy sector 11.67
Trade and service sector 1.53
Industry sector 30.96
Agriculture sector 7.13
Environmental service sector 98.94
Refineries 4.48
Drinking-water companies 90.42
Consumers 59.47
Total 139.08 769.00BMC Public Health 2007, 7:252 http://www.biomedcentral.com/1471-2458/7/252
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reason, assessing face validity was not possible. However,
for the validity and to prevent double counting of spend-
ing on prevention we collected data from executive organ-
izations, and as much as possible used published annual
reports and formal balance sheets.
A third limitation of our study is the use of PARs as a
methodology to allocate costs of preventive activities to
disease groups. Two important limitations of the PAR
methodology are that 1) some causes of disease can be
synergistic so that PARs sum to more than 100%, and 2)
PARs vary in the scientific literature [38].
It is difficult to judge whether our findings are generaliza-
ble to other countries due to the lack of comparable stud-
ies. Total prevention expenditures in the USA were
estimated at $188 per capita in 1988 (adjusted to price
level 2003) [4], which is much lower than our estimate of
$832 (in PPP dollars) in 2003 ($PPP = €0.924). The pro-
portion of health protection in total prevention expendi-
tures was much lower (30%) than in our study (82%). In
contrast, the proportions spent on health promotion and
disease prevention were higher in the USA (24% and
35%, respectively) compared to our estimate (2% and
16%, respectively). However, both studies showed that
the total amount spent on prevention was much higher
than prevention expenditures within the NHA only. The
OECD recently estimated for 22 OECD countries the
expenditures on prevention and public health within the
national health budget [5]. However, these estimates did
not reflect the total amount spent on prevention, but
rather preventive services provided in the form of public
and private programs. As opposed to our study, the OECD
could not estimate expenditures on prevention provided
through ambulatory care, and did not include health-
related expenditures (e.g. environmental health). It
should be noted that our study did not aim to present a
completely elaborated health account alternative for esti-
mating national spending on prevention. It is, rather,
more a complementary system using another perspective
than that used for the existing statistics for prevention,
and it might be an eye-opener regarding current defini-
tions and classifications of prevention in NHA and classi-
fications such as the SHA. Nevertheless, comprehensive
testing of our approach into practice could be a step
towards a better health account alternative.
The proportion of health promotion in total prevention
expenditures (2%, e.g. €15 per capita) is small compared
to the health burden that can be attributed to harmful
health behavior. In the Netherlands 13% of the total bur-
den of disease can be attributed to smoking, 10% to over-
weight and obesity, 8% to hypertension, and 4% to
physical inactivity [34]. Although health promotion activ-
ities were difficult to identify in, for instance, occupa-
tional health centers and among general practitioners
(GPs), this would not substantially raise a true estimate.
National spending on prevention versus curative services and  care by disease group (ICD-9 chapters), in the Netherlands  in 2003, in   per capita Figure 3
National spending on prevention versus curative services and 
care by disease group (ICD-9 chapters), in the Netherlands 
in 2003, in € per capita.
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National spending on health promotion and disease preven- tion by age group, in the Netherlands in 2003,   capita Figure 2
National spending on health promotion and disease preven-
tion by age group, in the Netherlands in 2003, in € per capita.
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Successful health promotion may reduce premature mor-
tality and improve quality of life, and may save resources
[39-42], but so far the evidence for this is scarce. For exam-
ple, Feenstra et al. [43] showed that minimal GP counsel-
ling is an effective and cost-saving anti-smoking
intervention. Dickinson et al. [44] found robust effects on
hypertension for interventions aiming at improved diet,
physical exercise, alcohol and sodium restriction, and fish
oil supplements. Elley et al. [45] showed that verbal and
written physical activity advice given by GPs with tele-
phone follow-up is an inexpensive way of increasing activ-
ity for sedentary people, whilst enabling significant
economic impact through reduction of cardiovascular
(and other) morbidity and mortality. These interventions
are in general not expensive. Lleras-Muney [46] showed
that the benefits of education are large enough to warrant
education policies being considered more seriously as a
means to increase health. In health policy considerable
attention is paid to the promotion of healthy behaviors
[47,48], but apparently further steps are necessary to
implement evidence-based and cost-effective health pro-
motion activities on a wider scale. Research on how to
improve strategies to overcome obstacles and facilitate
implementation is still needed.
A significant relationship is expected between the high
expenditures on prevention of infectious diseases and
injuries, and the respectively low expenditures on curative
services and long-term care. Strategies to combat these
health problems by regulation and preventive technolo-
gies have been successful, and provide a clear motive to
investigate whether the potential of preventive strategies
in other public health areas (e.g. mental health, cardiovas-
cular risk management) has been sufficiently reached [1].
Particularly mental disorders and diseases of the muscu-
loskeletal system involve high costs of medical and social
services, in sharp contrast with low expenditures on pre-
vention. Whether or not prevention will lead to extensive
savings will depend on the availability and cost effective-
ness of those preventive activities. Despite some progres-
sion, preventive activities are still missing for many
diseases.
Relatively high amounts are spent on health protection
measures such as air quality, drinking water systems,
domestic waste disposal and traffic safety measures. Some
of these have provided considerable value for money. For
instance, the implementation of clean water systems in
American cities substantially reduced mortality in the 19th
and early 20th century, with very favorable cost effective-
ness ($500 per life year saved in 2003 dollars) [2]. This
will be similar in countries with a similar developmental
path. Generally, however, not much is known about the
cost effectiveness of health protection measures, and
available estimates range from cost saving to high
amounts per life year or QALY saved. Regarding traffic
safety, seat belt use is cost saving, a driver's and dual air-
bag cost $24,000 and $61,000 per QALY saved, respec-
tively (in 1993 dollars) [49], whereas these estimates are
generally unknown for infrastructural safety investments.
Information on cost effectiveness is even more scarce for
environmental safety measures, and results are generally
uncertain, and more unfavorable than for many preven-
tive measures within health care (e.g. $54,000 per life year
saved for radon mitigation in houses [50]). More insight
into the cost effectiveness of these preventive measures
will probably save lives more effectively [6]. Given the
available evidence on the relative cost effectiveness of pre-
ventive and curative interventions, it is questionable
whether the current resource allocation, and particularly
the low share of health promotion activities, is efficient
and in line with societal preferences.
Conclusion
We conclude that the total expenditures on health-related
prevention in the Netherlands is much higher than usu-
ally reported due to the inclusion of health protection
activities beyond the NHA and SHA. The low share of
health promotion activities in total expenditures is note-
worthy. Because the health effects of many costly health
protection activities are unknown or uncertain, this can
only partly be due to the lack of available evidence on
effectiveness and cost effectiveness. A systematic assess-
ment of available evidence on the cost effectiveness of pre-
ventive and curative interventions could lead to more
investments in prevention directed at health behavior.
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